Press releases
- European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care
- Photocure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
- Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting
- Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN
- Photocure ASA: Results for the fourth quarter of 2023
More ▼
Key statistics
As of last trade, Photocure ASA (PHS:BER) traded at 4.62, 31.62% above the 52 week low of 3.51 set on Aug 25, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.61 |
---|---|
High | 4.65 |
Low | 4.54 |
Bid | 4.52 |
Offer | 4.75 |
Previous close | 4.62 |
Average volume | 0.00 |
---|---|
Shares outstanding | 27.12m |
Free float | 26.68m |
P/E (TTM) | 7,576.60 |
Market cap | 1.48bn NOK |
EPS (TTM) | 0.0072 NOK |
Data delayed at least 15 minutes, as of Apr 25 2024 17:46 BST.
More ▼